Share articleAs U.S. lawmakers debate issues around health care for transgender youth, it’s been difficult to determine the ...

Less than one in 1,000 US adolescents receive gender-affirming medication, researchers have revealed ahead of Trump's second ...

Researchers say among those with private insurance, not one transgender person under 12 was prescribed gender-affirming hormones. “There’s not some massive wave of folks accessing care,” the report's ...

The study, published in JAMA Pediatrics on Monday, looked at private insurance claims representing over 5 million patients in ...

A new analysis of private insurance claims data finds less than 0.1% of youth accessed puberty blockers or hormones for ...

Fewer than 1 in 1,000 U.S. adolescents with commercial insurance received gender-affirming medications -- puberty blockers or ...

Less than 1 in 1,000 adolescents with commercial insurance received gender-affirming medication over a five-year period, ...

I am still enough of an institutionalist that it pains me to hear Supreme Court justices embarrassing ... that urged caution in the provision of puberty blockers to teens, Alito engaged in a ...

Experts believe the Supreme Court’s decision in the case could ... who admitted to not publicizing a study that found puberty blockers didn't lead to mental health improvements, for fear of ...